CAPRELSA - 0310-7820-30 - (Vandetanib)

Alphabetical Index


Drug Information of CAPRELSA

Product NDC: 0310-7820
Proprietary Name: CAPRELSA
Non Proprietary Name: Vandetanib
Active Ingredient(s): 100    mg/1 & nbsp;   Vandetanib
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of CAPRELSA

Product NDC: 0310-7820
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022405
Marketing Category: NDA
Start Marketing Date: 20110725

Package Information of CAPRELSA

Package NDC: 0310-7820-30
Package Description: 30 TABLET in 1 BOTTLE, PLASTIC (0310-7820-30)

NDC Information of CAPRELSA

NDC Code 0310-7820-30
Proprietary Name CAPRELSA
Package Description 30 TABLET in 1 BOTTLE, PLASTIC (0310-7820-30)
Product NDC 0310-7820
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Vandetanib
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20110725
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name VANDETANIB
Strength Number 100
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of CAPRELSA


General Information